Learn More
Medchemexpress LLC 1H-1,2,4-Triazol-3-amine, 5-[4-[(2S,5S)-5-[(4-chlorophenyl)methyl]-2-methyl-4-morpholinyl]... | 2088453-21-6 | 99.9% | 390.91 | 1 ML

Supplier: Medchemexpress LLC HY137464A10MM/1ML
OATD-01 is a highly potent, first-in-class, orally active, and selective chitinase inhibitor. It demonstrates low nanomolar activity towards CHIT1 and exhibits an excellent pharmacokinetic profile across multiple species. This compound shows significant antifibrotic efficacy in vivo and is being investigated for pulmonary fibrosis (IPF) research.
- Highly potent and selective chitinase inhibitor
- Low nanomolar activity towards CHIT1 (hCHIT1, IC50=23 nM)
- Excellent pharmacokinetic profile across multiple species
- Selective against a panel of off-targets
- Significant antifibrotic efficacy in vivo
- Suitable for pulmonary fibrosis (IPF) research
- Exhibits high affinity toward h/mCHIT1 and h/mAMCase
- Reduced lung fibrosis in animal models
- Clinical trials are underway for pulmonary sarcoidosis (Phase 2)
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.